U.S. Physical Therapy, Inc. · NYSE:USPH

U.S. Physical Therapy — Investor Presentation (March 2023)

35 slides from U.S. Physical Therapy's investor presentation, Mar 2, 2023

  1. Slide 1: Investor Presentation March 2, 2023

    TM Investor Presentation March 2, 2023

  2. Slide 2: Disclaimer

    Disclaimer Forward Looking Statements This presentation contains forward-looking statements, which involve numerous risks and uncertainties. Included are statements relating to opening of new clinics, availability of personnel and reimbursement environment. The forward-looking statements are based o

  3. Slide 3: Investment Highlights

    Investment Highlights • As of December 31, 2022, operated 640 outpatient physical and occupational therapy clinics across 40 states Established • One of the largest owner/operator of PT clinics Company • Growing Industrial Injury Prevention business • One of two publicly-traded, pure play providers

  4. Slide 4: Focused Business Model

    Focused Business Model • Specialize in trauma, sports, work-related and pre- and post-surgical cases • Partner with experienced physical therapists – Drive volume via referrals – Augment sales with marketing reps • Historical focus on organic growth via lower cost de novo (start-up) clinics • Strate

  5. Slide 5: Large and Growing Market Opportunity

    Large and Growing Market Opportunity • $30B+ U.S. rehab market with projected growth • Favorable demographics – physically active, aging and obese population segments • Untapped market potential – each year ~50% of Americans over the age of 18 develop a musculoskeletal injury that lasts more than 3

  6. Slide 6: Setting for Physical Therapy Care

    Setting for Physical Therapy Care Within physical therapy, outpatient clinics are the leading setting for care. 100% Other Offices of physicians 80% Home health total 60% Hospitals; state, local, and private 40% 20% Outpatient clinics 0% • Orthopedic rehab is the primary driver of physical therapy s

  7. Slide 7: Payers See Significant ROI for Physical Therapy

    Payers See Significant ROI for Physical Therapy Without PT Hip replacement Hip replacement surgery ($56,000) surgery ($56,000) Inpatient care Inpatient care ($15,000) ($15,000) Outpatient Physical Home Therapy Clinic Readmission Readmission Rate of 10% Rate of 20% Full Recovery Full Recovery Total T

  8. Slide 8: Competitive Landscape

    Competitive Landscape • Highly fragmented U.S. outpatient rehab market with 37,000 + clinics(1) • No company with >10% market share • USPh is one of the largest owner/operator of PT clinics – Select Medical/Physio 1,900+ Clinics (2) – ATI 900+ Clinics (2) – USPh 640 Clinics (2) (1) Source: “Industry

  9. Slide 9: Growth Strategy

    Growth Strategy Drive organic growth through de novo PT/OT clinic openings, utilize true partnership model Maximize profits of existing facilities by growing patient volume, improving pricing and increasing efficiencies Augment organic growth through strategic acquisitions 9

  10. Slide 10: USPH Partnership Advantages

    USPH Partnership Advantages Less Administrative More Resources Burden  Accounting  Access to Capital for Development of Additional  HR Clinics  Real Estate  Less Personal Financial Risk  Construction  Unlimited Earnings Potential  Purchasing  Full Benefit Package  Marketing  Ongoing Guida

  11. Slide 11: National Footprint

    National Footprint 640 Clinics in 40 States as of December 31, 2022 USPh ONE PARTNE!

  12. Slide 12: Acquisition Strategy

    Acquisition Strategy • Completed 47 acquisitions since 2005 • Range in size from 3 to 52 clinics • Acquisitions include five industrial injury prevention services businesses • Acquisition criteria:  Owner therapists continue to operate clinics and retain significant equity interest  Immediately ac

  13. Slide 13: Scale Advantages Create a Robust Business Case for Consolidation

    Scale Advantages Create a Robust Business Case for Consolidation • Increased likelihood of selection for payor networks  Scale is cited as a core criterion by specialty network managers and payors.  Some limited leverage in negotiations with payors for reimbursement • Higher likelihood of referrer

  14. Slide 14: New Clinics / Brands

    New Clinics / Brands NORTHERN LIGHTS NEE Se CLs PHYSICAL THERAPY 1a PLYMOUTH ea esemour 6 THERAPY GROUP > ei terinoton = Mera And Carbon County ¥Custom » ARISES micr <@ Ff x SUMMIT PHYSICAL THERAPY DESERT HAND PHYSICAL THERAPY of. MISSI@N * anny @iiics ) 5; Gree Ons Ae Rehabilitation ra yy ONE PARTN

  15. Slide 15: Executive Management

    Executive Management • Chris Reading – Chief Executive Officer – Joined USPh as COO in November 2003 – Promoted to CEO and Board in November 2004 – Previously Senior Vice President of Operations with HealthSouth, managed over 200 facilities including OP, ASC, DX Imaging and rehab hospital operations

  16. Slide 16: Revenue Mix by Payor Type

    Revenue Mix by Payor Type Revenue Mix by Payor Type Revenue Mix by Payor Type Year Ended December 31, 2022 Year Ended December 31, 2021 Other Other Workers 6% Workers 7% Comp Private Comp 10% Insurance & 10% Managed Care 47% 48% Private Insurance & 33% Managed 30% Medicare Care Medicare 4% 5% Medica

  17. Slide 17: Industrial Injury Prevention

    Industrial Injury Prevention • Both internally and through acquisition, USPh has expanded its industry-focused Industrial Injury Prevention Services business. • USPh made its initial acquisition in the Industrial Injury Prevention Services space in March 2017. • Since then, the business has grown bo

  18. Slide 18: USPH Total Revenue Mix

    USPH Total Revenue Mix Percentage of Revenue Percentage of Revenue For For the Year Ended December 31, 2022 Year Ended December 31, 2021 Industrial Injury Industrial Injury Prevention Services Prevention Services 14% 9% 86% 91% Physical Therapy Operations (including management contracts) Physical Th

  19. Slide 19: USPH Physical Therapy Growth Drivers

    USPH Physical Therapy Growth Drivers Prior to Covid-19 pandemic and in 2021 each driver showed robust growth Number of Clinics* 640 Daily Patient Visits Per Clinic 578 591 583 554 591 540 489 508 29.1 28.7 472 26.6 27.6 24.6 431 25.9 24.1 25 21.7 21.5 22.9 2012-2022 2012-2022 CAGR+4.0% CAGR +2.8% 12

  20. Slide 20: Physical Therapy Operations Annual Gross Margin Percentage

    Physical Therapy Operations Annual Gross Margin Percentage 26.0% 23.6% 23.8% 24.0% 23.1% 22.7% 22.0% 20.2% 20.0% 18.0% 16.0% 14.0% 12.0% 2018 2019 2020 2021 2022 Note: Excludes management contracts 20

  21. Slide 21: Physical Therapy Operations Quarterly Gross Margin Percentage

    Physical Therapy Operations Quarterly Gross Margin Percentage 26.0% 24.0% 22.0% 22.0% 21.0% 20.0% 20.0% 20.0% 18.7% 18.0% 16.0% 14.0% 12.0% Q4 2021 Q1 2022 Q2 2022 Q3 2023 Q4 2022 Note: Excludes management contracts 21

  22. Slide 22: Industrial Injury Prevention Annual Progression

    Industrial Injury Prevention Annual Progression $90.0 Revenue (In millions) 30.0% Margin Percentage (%) $80.0 $77.1 25.7% 24.4% 25.0% $70.0 22.4% 20.4% 20.7% $60.0 20.0% $50.0 $43.9 $39.2 15.0% 13.3% $40.0 $37.5 $30.0 $25.5 10.0% $20.0 5.0% $10.0 $4.9 $0.0 0.0% 2017 2018 2019 2020 2021 2022 2017 201

  23. Slide 23: Dividend

    Dividend • The Company initiated a quarterly dividend in 2011and has subsequently raised the quarterly dividend rate each year • Dividend increased from $0.41 per share to $0.43 per share in Q1 2023 • Dividend seen as an additional way to increase returns to shareholders • Dividends do not impact ou

  24. Slide 24: Daily Volumes Progression

    Daily Volumes Progression Record High Average Visits per Clinic per Day 30.0 29.5 29.8 29.5 28.8 29.1 28.2 27.5 28.0 27.7 27.1 27.9 26.9 26.2 25.8 18.9 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22  In April 2020, patient volumes were approximately 45% of pre-COVID

  25. Slide 25: Strong Cash Flow and Balance Sheet

    Strong Cash Flow and Balance Sheet • At December 31, 2022, we had $31.6 million in cash, $148.1 million outstanding on our term loan and $31.0 million outstanding on our revolving facility. We have $144.0 million still available for borrowings under our revolving facility. • De novo clinics (new cli

  26. Slide 26: Strong Return to Shareholders

    Strong Return to Shareholders Average Annual Rate of Return to Shareholders 42% Per Year $130.00 $120.00 • CEO joined Company in Fall of $110.00 2003 $100.00 • Total Cumulative Return through $90.00 December 31, 2022 including dividends is $99.07. $80.00 • Total Cumulative Return Percentage is 811.4

  27. Slide 27: Fourth Quarter 2022 and 2021 Results

    Fourth Quarter 2022 and 2021 Results Fourth Quarter Ended December 31, 2022 2021 (in thousands, except per share data) Revenue $ 141,182 $ 129,833 Gross profit 27,831 27,183 Operating income 6,794 16,465 GAAP Net income(1) 2,607 10,213 GAAP (Loss) earnings per share (0.01) 0.73 Non-GAAP Operating re

  28. Slide 28: Year Ended 2022 and 2021 Results

    Year Ended 2022 and 2021 Results Year Ended December 31, 2022 2021 (in thousands, except per share data) Revenue $ 553,144 $ 495,022 Gross profit 112,024 117,182 Operating income 56,801 70,649 GAAP Net income(1) 32,158 40,831 GAAP Earnings per share 2.25 2.41 Non-GAAP Operating results(2), with reli

  29. Slide 29: Segment Information – Year 2022 and 2021

    Segment Information – Year 2022 and 2021 Year Ended December 31, 2022 2021 (in millions, except percentages) Gross profit $ 112,024 $ 117,182 PT Gross profit $ 96,057 $ 106,488 PT Gross margin % 20.2% 23.6% Industrial injury prevention profit $ 15,967 $ 10,694 Industrial injury prevention margin 20.

  30. Slide 30: Segment Information – Fourth Quarter 2022 and 2021 Results

    Segment Information – Fourth Quarter 2022 and 2021 Results Fourth Quarter Ended December 31, 2022 2021 (in millions, except percentages) Gross profit $ 27,831 $ 27,183 PT Gross profit $ 24,543 $ 24,430 PT Gross margin % 20.0% 21.0% Industrial injury prevention profit $ 3,288 $ 2,753 Industrial injur

  31. Slide 31: Summary

    Summary Publicly-traded, pure play operator of rehab clinics Proven business model, driven by organic growth and acquisitions Significant scale with national footprint Large and growing market/favorable demographics Strong cash flow and balance sheet 31

  32. Slide 32: Appendix

    APPENDIX 32

  33. Slide 33: Reconciliation of Non-GAAP Financial Measures – Operating Results

    Reconciliation of Non-GAAP Financial Measures – Operating Results Three Months Ended December 31, Year Ended December 31, 2022 2021 * 2022 2021 * Computation of earnings per share - USPH shareholders: Net income attributable to USPH shareholders $ 2,607 $ 10,213 $ 32,158 $ 40,831 Charges to retained

  34. Slide 34: Reconciliation of Non-GAAP Financial Measures – Adjusted EBITDA

    Reconciliation of Non-GAAP Financial Measures – Adjusted EBITDA Three Months Ended December 31, Year Ended December 31, 2022 2021 * 2022 2021 * Net income attributable to USPH shareholders $ 2,607 $ 10,213 $ 32,158 $ 40,831 Adjustments: Depreciation and amortization 3,793 3,071 14,743 11,591 Goodwil

  35. Slide 35: USP

    USP ONE PARTNER

U.S. Physical Therapy — Investor Presentation (March 2023) on 6ix